News CVS Health Corporation

Equities

CVS

US1266501006

Healthcare Facilities & Services

Market Closed - Nyse Other stock markets 01:30:03 16/05/2026 am IST			5-day change	1st Jan Change
95.89 ^USD	-1.30%		+5.90%	+20.83%

15/05	Mubadala Investment Co PJSC raises share stake in AbbVie, Match Group, cuts in CVS Health	RE
14/05	Cvs Health® and Wgu launch online pre-pharmacy degree program for future pharmacists nationwide	RE

All News

Mentions Relevance

15/05	Mubadala Investment Co PJSC raises share stake in AbbVie, Match Group, cuts in CVS Health	RE
15/05	CVS Health's Annual Impact in Rhode Island	AQ
14/05	CVS Health: All Rhode Island CVS Pharmacy® Locations Now Accept WIC for Infant Formula	AQ
14/05	Cvs Health® and Wgu launch online pre-pharmacy degree program for future pharmacists nationwide	RE
14/05	CVS Health® and WGU launch online pre-pharmacy degree program for future pharmacists nationwide	PR
14/05	Morgan Stanley Adjusts Price Target on CVS Health to $106 From $93, Maintains Overweight Rating	MT
14/05	Argus Adjusts Price Target on CVS Health to $104 From $90, Maintains Buy Rating	MT
14/05	CVS unit Omnicare wins court approval for $250 million sale to GenieRx	RE
14/05	CVS Health Unit Omnicare Wins Court Approval to Sell Business to GenieRx	MT
14/05	Omnicare receives court approval for sale of business to GenieRx	RE
14/05	CVS unit Omnicare wins court approval for sale to GenieRx	RE
14/05	Omnicare Receives Court Approval for Sale of Business to GenieRx	PR
13/05	CVS Health Wins Gold in Enterprise AI, and Silver in Customer Experience AI at 2026 Stevie® (American Business Awards®) for Enterprise Scale AI Innovation	AQ
13/05	MinuteClinic highlights access and outcomes in clinically supervised weight-loss program	PR
12/05	Bernstein Adjusts CVS Health Price Target to $106 From $94, Maintains Outperform Rating	MT
12/05	JPMorgan Adjusts Price Target on CVS Health to $111 From $101, Maintains Overweight Rating	MT
11/05	TD Cowen Adjusts Price Target on CVS Health to $110 From $105	MT
07/05	CVS Health Increasingly Likely to Reach 3% Medicare Advantage Target Margin in 2028, RBC Says	MT
07/05	UBS Adjusts Price Target on CVS Health to $100 From $97, Maintains Buy Rating	MT
07/05	RBC Capital Adjusts CVS Health Price Target to $107 From $93, Maintains Outperform Rating	MT
07/05	CVS Health's Annual Impact in Connecticut	AQ
07/05	Deutsche Bank Adjusts CVS Health Price Target to $92 From $88, Maintains Buy Rating	MT
07/05	CVS Health : MinuteClinic® and Hartford HealthCare expand primary care access across Connecticut	PU
07/05	DA Davidson Raises Price Target on CVS Health to $100 From $80, Keeps Buy/Add Rating	MT
07/05	Truist Adjusts Price Target on CVS Health to $102 From $98, Maintains Buy Rating	MT